FDA Adds Liver Safety Warning To AbbVie Hepatitis C Drugs
The U.S. Food and Drug Administration on Thursday warned that two hepatitis C treatments manufactured by AbbVie Inc. can cause serious liver injury in patients with underlying advanced liver disease and...To view the full article, register now.
Already a subscriber? Click here to view full article